chronic diseases

Analysts tip Inventiva’s lanifibranor as NASH blockbuster

https://pharmaphorum.com/news/analyst-tip-inventivas-lanifibranor-as-nash-blockbuster-after-trial-win/

Celltrion buys drug portfolio from Takeda, ventures into chronic diseases

https://pharmaphorum.com/news/celltrion-ventures-into-chronic-diseases-with-takeda-portfolio-buy/

Digital therapeutics and their impact on society

https://pharmaphorum.com/partner-content/digital-therapeutics-and-their-impact-on-society/

Updates on Delivery Mechanisms of RNA-Based Drugs at RNA Therapeutics Conference

https://pharmaphorum.com/partner-content/updates-on-delivery-mechanisms-of-rna-based-drugs-at-rna-therapeutics-conference/

Nokia to debut digital health range this summer

https://pharmaphorum.com/news/nokia-debut-re-branded-withings-digital-health-range-summer/

Sensely raise $8m to develop ‘Virtual Nurse’ app

https://pharmaphorum.com/news/virtual-nurse-app-dramatically-reduces-hospital-readmissions/

BodyCap to bring space wearables to consumers in 2017

https://pharmaphorum.com/news/bodycap-bring-space-wearables-consumers-2017/

Tapping Latin America’s healthcare market

https://pharmaphorum.com/views-and-analysis/tapping-latin-america-s-healthcare-market/

Close in 10 seconds

Pharmaphorum.com

Search